Skip to main content
. 2020 May 30;24:100610. doi: 10.1016/j.ymgmr.2020.100610

Fig. 3.

Fig. 3

Clinical course of patient 2 before and after initiation of bezafibrate.

Bezafibrate was started at the age of 2 years and myopathic attack was completely prevented for 3 years. However, rhabdomyolysis developed again at the age of 5 years. Therefore, exercise restriction was initiated. Myopathic attack did not develop again from 6 years old onward. CK, creatine kinase.